The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
2 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $505,049 in first-year total cost, median $252,525.
Most frequent study sections
- Special Emphasis Panel[ZHG1 HGR-N (M1)]2
Most frequent institutions
- CAERUS MOLECULAR DIAGNOSTICS, INC.1
- EVE BIOMEDICAL, INC.1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2014 | Enzyme Switch: many reporter molecules from a single-molecule-sequencing product1R43HG007843-01 | FARINAS, JAVIER | CAERUS MOLECULAR DIAGNOSTICS, INC., CA | $255,049 | ZHG1 |
| 2014 | Sequencing by transcription using single-molecule field-effect transistors1R43HG007871-01 | KOTSEROGLOU, THEOFILOS | EVE BIOMEDICAL, INC., CA | $250,000 | ZHG1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-10-0.1.1. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.